{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:42:58Z","timestamp":1792798978726,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11046-021-00607-4","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T13:02:49Z","timestamp":1638450169000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Mucormycosis in Mainland China: A Systematic Review of Case Reports"],"prefix":"10.1007","volume":"187","author":[{"given":"Lin-Wei","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Qiu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3066-4049","authenticated-orcid":false,"given":"Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"5","key":"607_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634\u201353.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"607_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12879-017-2381-1","volume":"17","author":"Y Song","year":"2017","unstructured":"Song Y, Qiao J, Giovanni G, Liu G, Yang H, Wu J, et al. Mucormycosis in renal transplant recipients: review of 174 reported cases. BMC Infect Dis. 2017;17(1):283.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"607_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/13693780500464930","volume":"44","author":"A Chakrabarti","year":"2006","unstructured":"Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44(4):335\u201342.","journal-title":"Med Mycol"},{"issue":"1","key":"607_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","volume":"5","author":"H Prakash","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi. 2019;5(1):26.","journal-title":"J Fungi"},{"issue":"2","key":"607_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/BCR.0b013e31816673b1","volume":"29","author":"JP Ledgard","year":"2008","unstructured":"Ledgard JP, van Hal S, Greenwood JE. Primary cutaneous zygomycosis in a burns patient: a review. J Burn Care Res. 2008;29(2):286\u201390.","journal-title":"J Burn Care Res"},{"issue":"9","key":"607_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3201\/eid1509.090334","volume":"15","author":"D Bitar","year":"2009","unstructured":"Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006. Emerg Infect Dis. 2009;15(9):1395\u2013401.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"607_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","volume":"47","author":"G Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503\u20139.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"607_CR8","doi-asserted-by":"publisher","first-page":"811e1","DOI":"10.1016\/j.cmi.2016.03.029","volume":"22","author":"A Kyvernitakis","year":"2016","unstructured":"Kyvernitakis A, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect. 2016;22(9):811e1-e8.","journal-title":"Clin Microbiol Infect."},{"issue":"12","key":"607_CR9","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405\u201321.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"607_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","volume":"53","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Chen SC, et al. Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports. Int J Antimicrob Agents. 2019;53(5):589\u201397.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"607_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26\u201334.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"607_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"607_CR13","first-page":"7","volume":"7","author":"LL Ma","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.","journal-title":"Mil Med Res"},{"issue":"1\u20132","key":"607_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11046-014-9770-4","volume":"178","author":"D Kang","year":"2014","unstructured":"Kang D, Jiang X, Wan H, Ran Y, Hao D, Zhang C. Mucor irregularis infection around the inner canthus cured by amphotericin B: a case report and review of published literatures. Mycopathologia. 2014;178(1\u20132):129\u201333.","journal-title":"Mycopathologia"},{"issue":"1","key":"607_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bjd.17144","volume":"180","author":"X Wang","year":"2019","unstructured":"Wang X, Wang A, Wang X, Li R, Yu J. Cutaneous mucormycosis caused by Mucor irregularis in a patient with CARD9 deficiency. Br J Dermatol. 2019;180(1):213\u20134.","journal-title":"Br J Dermatol"},{"issue":"6","key":"607_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11046-020-00487-0","volume":"185","author":"X Wang","year":"2020","unstructured":"Wang X, Ding H, Chen Z, Zeng X, Sun J, Chen H, et al. CARD9 deficiency in a Chinese man with cutaneous mucormycosis, recurrent deep dermatophytosis and a review of the literature. Mycopathologia. 2020;185(6):1041\u201350.","journal-title":"Mycopathologia"},{"issue":"1","key":"607_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/JCM.06133-11","volume":"50","author":"RG Vitale","year":"2012","unstructured":"Vitale RG, de Hoog GS, Schwarz P, Dannaoui E, Deng S, Machouart M, et al. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. J Clin Microbiol. 2012;50(1):66\u201375.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 3","key":"607_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/myc.12234","volume":"57","author":"A Chowdhary","year":"2014","unstructured":"Chowdhary A, Kathuria S, Singh PK, Sharma B, Dolatabadi S, Hagen F, et al. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses. 2014;57(Suppl 3):97\u2013107.","journal-title":"Mycoses"},{"key":"607_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00653-19","author":"L Wagner","year":"2019","unstructured":"Wagner L, de Hoog S, Alastruey-Izquierdo A, Voigt K, Kurzai O, Walther G. A revised species concept for opportunistic mucor species reveals species-specific antifungal susceptibility profiles. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.00653-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"607_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/myc.12897","volume":"62","author":"A Manesh","year":"2019","unstructured":"Manesh A, Rupali P, Sullivan MO, Mohanraj P, Rupa V, George B, et al. Mucormycosis-A clinicoepidemiological review of cases over 10 years. Mycoses. 2019;62(4):391\u20138.","journal-title":"Mycoses"},{"issue":"4","key":"607_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/mmy\/myy060","volume":"57","author":"H Prakash","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med Mycol. 2019;57(4):395\u2013402.","journal-title":"Med Mycol"},{"issue":"9","key":"607_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/myc.12958","volume":"62","author":"M Nucci","year":"2019","unstructured":"Nucci M, Engelhardt M, Hamed K. Mucormycosis in South America: a review of 143 reported cases. Mycoses. 2019;62(9):730\u20138.","journal-title":"Mycoses"},{"issue":"7","key":"607_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/myc.12474","volume":"59","author":"A Vaezi","year":"2016","unstructured":"Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H. Mucormycosis in Iran: a systematic review. Mycoses. 2016;59(7):402\u201315.","journal-title":"Mycoses"},{"issue":"10","key":"607_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/myc.13123","volume":"63","author":"J Stemler","year":"2020","unstructured":"Stemler J, Hamed K, Salmanton-Garcia J, Rezaei-Matehkolaei A, Grafe SK, Sal E, et al. Mucormycosis in the Middle East and North Africa: analysis of the FungiScope((R)) registry and cases from the literature. Mycoses. 2020;63(10):1060\u20138.","journal-title":"Mycoses"},{"issue":"12","key":"607_CR25","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","volume":"17","author":"A Skiada","year":"2011","unstructured":"Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) working group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17(12):1859\u201367.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"607_CR26","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/cid\/cir880","volume":"54","author":"F Lanternier","year":"2012","unstructured":"Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007). Clin Infect Dis. 2012;54(Suppl 1):S35-43.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"607_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.clindermatol.2012.01.010","volume":"30","author":"A Skiada","year":"2012","unstructured":"Skiada A, Rigopoulos D, Larios G, Petrikkos G, Katsambas A. Global epidemiology of cutaneous zygomycosis. Clin Dermatol. 2012;30(6):628\u201332.","journal-title":"Clin Dermatol"},{"issue":"2","key":"607_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1346-8138.12736","volume":"42","author":"S Yamaguchi","year":"2015","unstructured":"Yamaguchi S, Okubo Y, Katano A, Sano A, Uezato H, Takahashi K. Primary cutaneous mucormycosis caused by Mucor irregularis in an elderly person. J Dermatol. 2015;42(2):210\u20134.","journal-title":"J Dermatol"},{"issue":"6","key":"607_CR29","doi-asserted-by":"publisher","first-page":"e0179136","DOI":"10.1371\/journal.pone.0179136","volume":"12","author":"J Guinea","year":"2017","unstructured":"Guinea J, Escribano P, Vena A, Munoz P, Martinez-Jimenez MDC, Padilla B, et al. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates. PLoS One. 2017;12(6):e0179136.","journal-title":"PLoS One."},{"issue":"3","key":"607_CR30","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/AAC.04435-14","volume":"59","author":"A Espinel-Ingroff","year":"2015","unstructured":"Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E, Dufresne P, et al. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrob Agents Chemother. 2015;59(3):1745\u201350.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"607_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","volume":"39","author":"JJ Vehreschild","year":"2013","unstructured":"Vehreschild JJ, Birtel A, Vehreschild MJ, Liss B, Farowski F, Kochanek M, et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol. 2013;39(3):310\u201324.","journal-title":"Crit Rev Microbiol"},{"key":"607_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13338","author":"R Pal","year":"2021","unstructured":"Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, et al. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021. https:\/\/doi.org\/10.1111\/myc.13338.","journal-title":"Mycoses"},{"key":"607_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.08.005","author":"JJY Ong","year":"2021","unstructured":"Ong JJY, Chan ACY, Sharma AK, Sharma S, Sharma VK. The mucormycosis epidemic within COVID-19 pandemic- lessons from India. Brain Behav Immun. 2021. https:\/\/doi.org\/10.1016\/j.bbi.2021.08.005.","journal-title":"Brain Behav Immun"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-021-00607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-021-00607-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-021-00607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T11:16:29Z","timestamp":1643714189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-021-00607-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1007\/s11046-021-00607-4","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}